Cardiogen (20mg) is a synthetic short-chain peptide supplied exclusively for controlled laboratory research, analytical evaluation, and in vitro experimentation. It is commonly identified by the amino acid sequence Ala-Glu-Asp-Arg (AEDR).
Laboratory investigations involving Cardiogen may examine peptide identity, physicochemical properties, stability, and interactions within controlled cardiovascular-derived cellular models. Any references to cardiac, myocardial, or vascular systems describe areas of experimental study only and do not indicate therapeutic properties or intended outcomes.
Each vial contains 20mg of lyophilized research material. Lot-specific analytical documentation is available through the Nordsci Certificate of Analysis library.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions. THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Cardiogen (20mg) is a synthetic tetrapeptide supplied as a lyophilized research material for laboratory analysis and controlled in vitro experimentation. Cardiogen is commonly represented by the amino acid sequence Ala-Glu-Asp-Arg, abbreviated AEDR.
Laboratory research involving Cardiogen may examine peptide characterization, analytical identity, stability, and interactions within cardiovascular-derived experimental systems. These investigations are conducted to evaluate molecular behavior under defined laboratory conditions and do not establish clinical efficacy, safety, or suitability for any human or veterinary application.
Cardiogen (20mg) – Research Specifications:
| Compound | Cardiogen |
| Quantity | 20mg per vial |
| Sequence | Ala-Glu-Asp-Arg (AEDR) |
| Compound Type | Synthetic tetrapeptide research material |
| Form | Lyophilized powder |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis for reported analytical results |
| Analytical Documentation | Lot-specific documentation is available through the COA Library |
| Storage Conditions | Store sealed in a cool, dry environment protected from light, heat, and moisture |
| Research Classification | Supplied exclusively for laboratory research and analytical use |
| Restrictions | Not for human or animal consumption or in vivo, diagnostic, therapeutic, food, drug, cosmetic, or dietary-supplement use |
Cardiogen is a synthetic short-chain peptide used as a laboratory research material. Its four-amino-acid sequence provides researchers with a defined compound for analytical characterization and controlled studies involving peptide behavior, stability, and molecular interactions.
In vitro research may use Cardiogen in experimental systems containing cardiac- or vascular-derived cells. These models allow researchers to observe molecular interactions under predetermined conditions, document experimental variables, and compare findings across controlled samples.
References to cardiovascular, myocardial, vascular, or cardiac research describe the type of laboratory model being examined. They do not indicate that Cardiogen maintains, restores, protects, or changes the function of a human or animal organ.
Important Research Notice: Nordsci research materials are supplied with access to lot-specific analytical documentation. Researchers should consult the applicable Certificate of Analysis for information concerning compound identity and analytical testing.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. IT IS NOT FOR HUMAN OR ANIMAL CONSUMPTION. IT IS NOT INTENDED FOR IN VIVO, DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR DIETARY-SUPPLEMENT USE.
Controlled in vitro studies may use Cardiogen when examining molecular interactions in cardiomyocyte-derived experimental systems. Research endpoints should be defined through validated laboratory protocols and interpreted only within the limitations of the selected model.
Laboratory models may be designed to observe peptide-associated molecular activity in cardiovascular-derived cell cultures. The phrase “tissue maintenance” identifies an experimental research category and does not represent a claim that Cardiogen maintains or changes cardiovascular tissue in humans or animals.
Cardiogen may be evaluated in controlled vascular-derived cellular systems to document its interaction with selected molecular targets or signaling markers. Findings from these experiments remain specific to the conditions, controls, and analytical methods used.
Researchers may include Cardiogen in in vitro models designed to measure predefined cellular markers under controlled experimental stress conditions. These studies are limited to laboratory observation and do not establish protective, restorative, or therapeutic effects.
Cardiogen (20mg) should be handled only by qualified laboratory personnel using established procedures for research peptides. Laboratories should maintain appropriate records for product receipt, lot identification, storage conditions, sample allocation, testing methods, and experimental disposal.
Protocol Design Considerations: Experimental outcomes may vary based on sample preparation methods, model selection, environmental conditions, control design, analytical instrumentation, and acceptance criteria. Researchers are responsible for selecting validated procedures appropriate to their intended in vitro or analytical work.
No dosing, reconstitution, injection, administration, or application guidance is provided. Cardiogen is not intended for use in humans or animals.
Note: This information is provided exclusively as a laboratory research reference. All work should be conducted by qualified personnel in appropriately equipped facilities and in accordance with applicable institutional requirements.
Lot-specific Certificates of Analysis provide analytical information associated with the applicable Cardiogen product lot. Documentation may include identity, purity, testing methodology, and other reported analytical results.
Researchers should verify that the lot number on the product corresponds with the lot number shown on the applicable COA. Analytical results apply only to the tested lot and should not be interpreted as evidence of clinical safety, therapeutic effectiveness, or approval for human or veterinary use.
Nordsci Peptides supplies Cardiogen (20mg) as a research-grade laboratory material with access to lot-specific analytical documentation. Laboratories sourcing peptide materials should evaluate compound identity, analytical results, storage requirements, batch traceability, and internal procurement standards before use.
IMPORTANT: Cardiogen (20mg) is sold exclusively for laboratory research and analytical use. It is not a drug, food, dietary supplement, cosmetic, or therapeutic product. It is not approved for human or veterinary use and must not be used for consumption, diagnosis, treatment, prevention, or any in vivo procedure.
